Talantbek A. Batyraliev

Talantbek A. Batyraliev

Auto-generated profile, based on publicly available information

Talantbek A. Batyraliev

Salymbekov University, Bishkek

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
CTCemal Tuncer
Cemal Tuncer
TBTalantbek Batyraliev
Talantbek Batyraliev
RYRemzi Yilmaz
Remzi Yilmaz
MGMustafa Gokce
Mustafa Gokce
BEBeyhan Eryonucu
Beyhan Eryonucu
SKSedat Koroglu
Sedat Koroglu

1 January 2008 in Circulation Journal
Verified
Journal Article
Closed access
AAAhmet Akcay
Ahmet Akcay
CTCemal Tuncer
Cemal Tuncer
TBTalantbek Batyraliev
Talantbek Batyraliev
MGMustafa Gokce
Mustafa Gokce
BEBeyhan Eryonucu
Beyhan Eryonucu
RYRemzi Yilmaz
Remzi Yilmaz
Isolated single coronary artery (SCA) is an extremely rare congenital coronary anomaly. Some subgroups of SCA can lead to angina pectoris, acute myocardial infarction or even sudden death in the absence of atherosclerosis. Young patients, especially, have the risk of serious clinical events, but middle-aged-to elderly patients have a variable clinical course. The aim of this study was to present the clinical and angiographic properties, relatively long-term follow-up (54+/-14 months) and management of adult patients (mean age 57+/-12 years) with SCA. The records of 70,850 patients undergoing coronary angiography between 1999 and 2005 were reviewed. Ten patients (0.024%) were found to have SCA, originating from the left sinus of Valsalva in 3 (30%) patients and from the right sinus of Valsalva in 7 patients (70%). No atherosclerotic involvement was seen in 7 (70%) patients. One patient was also treated by stent implantation to the SCA. Other patients were followed medically. All patients have been followed uneventfully. Medical treatment is usually adequate for middle-aged to elderly patients with SCA in the absence of ischemia and/or acute coronary syndrome.

1 March 2002 in International Journal of Cardiology
Verified
Journal Article
Closed access
RAResat Ayalp
Resat Ayalp
AMAyfer Mavi
Ayfer Mavi
ASAlper Serçelik
Alper Serçelik
TBTalantbek Batyraliev
Talantbek Batyraliev
EGErdem Gümüsburun
Erdem Gümüsburun

28 November 2014 in Folia Morphologica
Verified
Journal Article
Closed access
STS. Turkmen
S. Turkmen
MYMustafa Yolcu
Mustafa Yolcu
ASA. Sertcelik
A. Sertcelik
Emrah IpekEmrah Ipek
Emrah Ipek
BDB. Dokumaci
B. Dokumaci
TBT. Batyraliev
T. Batyraliev
The aim of our study is to determine the incidence of single coronary artery (SCA). SCA is a rarely seen coronary anomaly in which the right coronary artery and the left main coronary artery arise from single aortic sinus. Although SCA has a benign course in most cases and its clinical significance is unknown, in some autopsy studies it was shown to be related to sudden cardiac death. SCA patients detected among 215,140 coronary angiographies (CAG) performed between 1998 and 2013 in SANKO Hospital were included in our study. The classification of CAG was made according to the two different classifications defined by Smith and Lipton and colleagues. A total number of 215,140 patients who underwent routine CAG were included in the study, and SCA was detected in 67 (0.031%) patients. There were 6 (9%) type R-I, 23 (34%) type R-II, 10 (15%) type R-III, 16 (24%) type L-I and 12 (18%) type L-II patients according to the angiographic classification. SCA is rarely seen during routine cardiac catheterisation and its incidence is 0.014-0.066% in angiographic series. In our study, the incidence was shown to be similar to the previous studies.

1 May 1997 in Angiology
Verified
Journal Article
Closed access
PDF file
ABAhmet Birand
Ahmet Birand
GKGulmira Z. Kudaiberdieva
Gulmira Z. Kudaiberdieva
TBTalantbek A. Batyraliev
Talantbek A. Batyraliev
FAFerit Akgul
Ferit Akgul
AUAyhan Usal
Ayhan Usal
Fifty-one patients (mean age 51.6 ± 7.1 years) with angiographically proven coronary artery disease (CAD) entered the study. In 26 patients (Group I), trimetazidine treatment started twenty-four hours after percutaneous transluminal coronary angioplasty (PTCA). Another 25 patients (Group II) without trimetazidine treatment were kept as controls. The groups were comparable by age, gender, risk factors of CAD, coronary anatomy, left ventricular performance, and heart rate variability indices at baseline state. Power spectral analysis of heart rate variability and two-dimensional and Doppler echocardiographic examinations were performed before PTCA, and twenty-four hours, ten days, thirty days, and three months after PTCA. A statistically significant improvement of left ventricular systolic performance (P<0.001), augmentation of the parasympathetic band of heart rate variability (P<0.001), and decline of P1/P2 ratio (P<0.01) were evident in patients treated with trimetazidine, while no apparent changes were observed in controls. The intergroup analysis also showed marked difference between groups as recorded on the day 30 and month 3 of observation (P<0.001). During follow-up period recurrences of angina pectoris and ischemia were registered in Group II, while no evidence of ischemia was discerned in Group I patients. In conclusion, trimetazidine modulates the autonomic control of heart rate, ie, reduces sympathetic overactivity and augments vagal influences, improves left ventricular contractility, and diminishes the clinical manifestations of ischemia in patients with CAD after PTCA.

1 May 2006 in International Journal of Cardiology
Verified
Journal Article
Closed access
NGNiyazi Guler
Niyazi Guler
TBTalantbek Batyraliev
Talantbek Batyraliev
HDHaluk Dulger
Haluk Dulger
COCenap Ozkara
Cenap Ozkara
MTMustafa Tuncer
Mustafa Tuncer
MAMehmet Agirbasli
Mehmet Agirbasli